Affiliations 

  • 1 Department of Social and Preventive Medicine, University of Malaya, Kuala Lumpur, Malaysia. [email protected]
  • 2 Modeling and Economics Unit, Public Health England, London, UK
  • 3 Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
  • 4 Department of Social and Preventive Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 5 Department of Paediatrics, University of Malaya, Kuala Lumpur, Malaysia
  • 6 Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Trop Med Int Health, 2016 Nov;21(11):1458-1467.
PMID: 27503549 DOI: 10.1111/tmi.12766

Abstract

OBJECTIVES: To evaluate rotavirus vaccination in Malaysia from the household's perspective. The extended cost-effectiveness analysis (ECEA) framework quantifies the broader value of universal vaccination starting with non-health benefits such as financial risk protection and equity. These dimensions better enable decision-makers to evaluate policy on the public finance of health programmes.

METHODS: The incidence, health service utilisation and household expenditure related to rotavirus gastroenteritis according to national income quintiles were obtained from local data sources. Multiple birth cohorts were distributed into income quintiles and followed from birth over the first five years of life in a multicohort, static model.

RESULTS: We found that the rich pay more out of pocket (OOP) than the poor, as the rich use more expensive private care. OOP payments among the poorest although small are high as a proportion of household income. Rotavirus vaccination results in substantial reduction in rotavirus episodes and expenditure and provides financial risk protection to all income groups. Poverty reduction benefits are concentrated amongst the poorest two income quintiles.

CONCLUSION: We propose that universal vaccination complements health financing reforms in strengthening Universal Health Coverage (UHC). ECEA provides an important tool to understand the implications of vaccination for UHC, beyond traditional considerations of economic efficiency.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.